美国 · 平台与数据 · MarketBeat
Royal Bank Of Canada Issues Pessimistic Forecast for Eyepoint Pharmaceuticals (NASDAQ:EYPT) Stock Price
Royal Bank Of Canada dropped their price objective on shares of Eyepoint Pharmaceuticals from $5.00 to $1.00 and set a "sector perform" rating for the company in a research note…
在 MarketBeat 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.marketbeat.com)
